Yellow fever and Hajj: with all eyes on Zika, a familiar flavivirus remains a threat

doi:10.1007/s11684-016-0487-2

Front. Med.

0, Vol.

Issue () : 527-530 https://doi.org/10.1007/s11684-016-0487-2

COMMENTARY

Yellow fever and Hajj: with all eyes on Zika, a familiar flavivirus remains a threat

Qanta A. Ahmed¹,Ziad A. Memish^2,³(

)

¹. Division of Pulmonary Disease and Critical Care Medicine, Department of Medicine, Winthrop University Hospital; State University of New York (SUNY) at Stony Brook, NY 11790, USA
². Ministry of Health, Riyadh 11514, Kingdom of Saudi Arabia
³. College of Medicine, Alfaisal University, Riyadh 11533, Kingdom of Saudi Arabia

Download: PDF(142 KB) HTML
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks

Abstract

Hajj is among the world’s largest mass gatherings, drawing between 2 and 3.5 million Muslims from 183 nations annually to perform pilgrimage in Mecca, Saudi Arabia. Infectious disease outbreaks can be imported both into the Hajj population and exported internationally by returning pilgrims. The domestic Saudi population can also be at risk of outbreaks traveling amid this mass migration. With yellow fever reported for the first time in China following the infection of expatriate Chinese workers in Angola and a full blown outbreak underway in wider West Africa, the prospect of yellow fever outbreaks in Asia threatens to impact Saudi Arabia, both during and beyond the Hajj season. With global focus trained on Zika, the rising threat of yellow fever cannot be overlooked. Strategies to mitigate risk to Saudi Arabia and the global population are thereby suggested.

Keywords yellow fever mass gathering Saudi Arabia Hajj Zika virus

Corresponding Author(s): Ziad A. Memish

Just Accepted Date: 15 September 2016 Online First Date: 17 October 2016 Issue Date: 01 December 2016

Cite this article:

Qanta A. Ahmed,Ziad A. Memish. Yellow fever and Hajj: with all eyes on Zika, a familiar flavivirus remains a threat[J]. Front. Med., 0, (): 527-530.

URL:

https://academic.hep.com.cn/fmd/EN/10.1007/s11684-016-0487-2
https://academic.hep.com.cn/fmd/EN/Y0/V/I/527

Tab.1 Comparison between yellow fever and Zika virus

Fig.1 Map of Saudi Arabia indicating all (sea, air, and land) ports of entry for Hajj.

1	Wasserman S, Tambyah PA, Lim PL. Yellow fever cases in Asia: primed for an epidemic. Int J Infect Dis 2016; 48: 98–103 https://doi.org/10.1016/j.ijid.2016.04.025 pmid: 27156836
2	Elachola H, Ditekemena J, Zhuo J, Gozzer E, Marchesini P, Rahman M, Sow S, Kattan RF, Memish ZA. Yellow fever outbreaks, vaccine shortages and the Hajj and Olympics: call for global vigilance. Lancet 2016 Sep 5. [Epub ahead of print] https://doi.org/10.1016/S0140-6736(16)31546-X
3	Wang L, Zhou P, Fu X, Zheng Y, Huang S, Fang B, Zhang G, Jia K, Li S. Yellow fever virus: increasing imported cases in China. J Infect 2016; 73(4):377–380 https://doi.org/DOI: 10.1016/j.jinf.2016.07.003 pmid: 27422700
4	Gulland A.Vigilance still needed to contain Africa’s yellow fever outbreak, says WHO. BMJ 2016; 354:i4756 https://doi.org/10.1136/bmj.i4756
5	Beasley DW, McAuley AJ, Bente DA. Yellow fever virus: genetic and phenotypic diversity and implications for detection, prevention and therapy. Antiviral Res 2015; 115: 48–70 PMID:25545072 https://doi.org/10.1016/j.antiviral.2014.12.010
6	Monath TP, Vasconcelos PF. Yellow fever. J Clin Virol 2015; 64: 160–173 https://doi.org/10.1016/j.jcv.2014.08.030 pmid: 25453327
7	Burki T. Yellow fever in Africa: a disaster waiting to happen. Lancet Infect Dis 2016; 16(8): 896–897 PMID:27477983 https://doi.org/10.1016/S1473-3099(16)30224-9
8	Maguire HC, Heymann DL. Yellow fever in Africa. BMJ 2016; 354: i3764 https://doi.org/10.1136/bmj.i3764 pmid: 27422309
9	WHO. Yellow fever global vaccine stockpile in emergencies. <Date>(Accessed September 10, 2016)</Date>
10	Jamie A. Yellow fever spreads rapidly in Africa, vaccine supply running low. <Date>(Accessed September 10, 2016)</Date>
11	Barrett AD. Yellow fever in Angola and beyond—the problem of vaccine supply and demand. N Engl J Med 2016; 375(4): 301–303 https://doi.org/10.1056/NEJMp1606997 pmid: 27276108
12	Kupferschmidt K. Yellow fever outbreak triggers vaccine alarm. Science 2016; 352(6282): 128–129 https://doi.org/10.1126/science.352.6282.128 pmid: 27124428
13	No authors listed. Health conditions for travellers to Saudi Arabia for the pilgrimage to Mecca (Hajj), 2016. Wkly Epidemiol Rec 2016; 91(26-27): 331–335 PMID:27372990
14	Mo Y, Alferez Salada BM, Tambyah PA. Zika virus—a review for clinicians. Br Med Bull 2016; 119(1): 25–36 https://doi.org/10.1093/bmb/ldw023 pmid: 27283145

[1]	Weibao Song, Hongjuan Zhang, Yu Zhang, Rui Li, Yanxing Han, Yuan Lin, Jiandong Jiang. Repurposing clinical drugs is a promising strategy to discover drugs against Zika virus infection[J]. Front. Med., 2021, 15(3): 404-415.
[2]	Xiaohuan Wang, Peng Zou, Fan Wu, Lu Lu, Shibo Jiang. Development of small-molecule viral inhibitors targeting various stages of the life cycle of emerging and re-emerging viruses[J]. Front. Med., 2017, 11(4): 449-461.
[3]	Ali A. Rabaan, Ali M. Bazzi, Shamsah H. Al-Ahmed, Jaffar A. Al-Tawfiq. Molecular aspects of MERS-CoV[J]. Front. Med., 2017, 11(3): 365-377.

Viewed

Full text

Abstract

Cited

Shared

Discussed